BIOENVISION

Genzyme Corporation

Application Filed: 2002-07-25
Trademark Application Details
Trademark Logo BIOENVISION

Mark For: BIOENVISION® trademark registration is intended to cover the categories of pharmaceuticals, namely therapeutic drugs administered in the treatment of cancer and autoimmune diseases. [all]

Status

2022-07-17 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number76434613
Registration Number3121124
Mark Literal ElementsBIOENVISION
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2006-06-14
Basis1(a)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation Code2
Attorney NameRichard D. Allison
Law Office AssignedL60
Employee NameDALIER, JOHN DAVID

Timeline

2002-07-25Application Filed
2003-01-07Published
2003-01-07Published for Opposition
2003-10-00Date of First Use
2003-10-01Date of First Use
2004-10-01Date of Use In Commerce
2006-06-14Location: PUBLICATION AND ISSUE SECTION
2006-07-25Trademark Registered
2013-03-01Cancelled
2013-03-01Status: Dead/Cancelled
2013-03-01Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: GENZYME CORPORATION
Address500 KENDALL STREET CAMBRIDGE, MASSACHUSETTS UNITED STATES 02142
Legal Entity TypeCorporation
Legal Entity StateNo Place Where Organized Found

Documents

ApplicationIMAGE/TIFF2002-07-25
DrawingIMAGE/TIFF2002-07-25
Duplicate Application2002-07-25
Duplicate Drawing2002-07-25
XSearch Search Summary2002-10-25
Unclassified-Other2002-10-28
Notice of Publication2002-12-18
Notice of AllowanceAPPLICATION/XML2003-03-21
Notice of Allowance2003-04-01
Extension of Time to File SOU2003-07-16
Paper Correspondence Incoming2003-07-16
ITU Extension ApprovalAPPLICATION/XML2003-12-17
Extension of Time to File SOU2004-03-11
Extension of Time to File SOUAPPLICATION/XML,IMAGE/TIFF2004-03-11
PR-Power of Attorney2004-03-18
Paper Correspondence Incoming2004-03-18
ITU Extension Approval2004-03-23
File Jacket2004-08-10
Unclassified2004-08-10
Extension of Time to File SOU2004-09-22
ITU Extension Approval2004-10-06
Extension of Time to File SOU2005-03-04
ITU Extension Approval2005-03-30
Paper Correspondence Incoming2005-04-22
Extension of Time to File SOU2005-09-08
ITU Extension Approval2005-09-10
Paper Correspondence Incoming2005-09-19
Paper Correspondence Incoming2006-02-07
Change of AddressIMAGE/TIFF2006-03-16
Specimen2006-03-16
Statement of Use2006-03-16
TRAM Snapshot of App at Pub for Oppostn2006-04-19
Notice of Acceptance of Statement of Use2006-06-15
Registration CertificateIMAGE/TIFF2006-07-25
TEAS Rev, App and/or COA of Atty/Dom.Rep2008-01-17
Teas Change of Owner Address2008-01-17

Attorney of Record

Richard D. Allison
Genzyme Corporation
Legal Department
15 Pleasant Street Connector
Framingham MA 01701

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICALS, NAMELY THERAPEUT
IC DRUGS ADMINISTERED IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES. FIRST USE: 20031000. FIRST USE IN COMMERCE: 20041000

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051PHARMACEUTICALS, NAMELY THERAPEUTIC DRUGS ADMINISTERED IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (6-YR)2013-03-01
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2008-03-05
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2008-01-17
TEAS CHANGE OF OWNER ADDRESS RECEIVED2008-01-17
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2008-01-17
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2008-01-1788888
REGISTERED-PRINCIPAL REGISTER2006-07-25
LAW OFFICE REGISTRATION REVIEW COMPLETED2006-06-0869712
ASSIGNED TO LIE2006-04-2169712
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2006-04-18
STATEMENT OF USE PROCESSING COMPLETE2006-04-0176873
USE AMENDMENT FILED2006-03-1676873
TEAS STATEMENT OF USE RECEIVED2006-03-16
TEAS CHANGE OF CORRESPONDENCE RECEIVED2006-03-16
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2006-03-0165362
PAPER RECEIVED2006-02-07
UNDELIVERABLE MAIL - NO ACTION TAKEN2005-09-2999888
PAPER RECEIVED2005-09-19
TEAS EXTENSION RECEIVED2005-09-08
SOU EXTENSION 5 GRANTED2005-09-0898765
SOU EXTENSION 5 FILED2005-09-0898765
UNDELIVERABLE MAIL - NO ACTION TAKEN2005-07-0671280
PAPER RECEIVED2005-04-22
SOU EXTENSION 4 GRANTED2005-03-2976874
TEAS EXTENSION RECEIVED2005-03-04
SOU EXTENSION 4 FILED2005-03-0476874
SOU EXTENSION 3 GRANTED2004-10-05
TEAS EXTENSION RECEIVED2004-09-22
SOU EXTENSION 3 FILED2004-09-22
CASE FILE IN TICRS2004-08-11
PAPER RECEIVED2004-03-18
TEAS EXTENSION RECEIVED2004-03-11
SOU EXTENSION 2 GRANTED2004-03-11
SOU EXTENSION 2 FILED2004-03-11
SOU EXTENSION 1 GRANTED2003-12-16
PAPER RECEIVED2003-07-16
SOU EXTENSION 1 FILED2003-07-14
NOA MAILED - SOU REQUIRED FROM APPLICANT2003-04-01
PUBLISHED FOR OPPOSITION2003-01-07
NOTICE OF PUBLICATION2002-12-18
APPROVED FOR PUB - PRINCIPAL REGISTER2002-10-28
ASSIGNED TO EXAMINER2002-10-2472503

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed